Tag: resistance to conventional cancer therapies

A recently published study in the journal Nature has unveiled a critical molecular pathway that not only drives the aggressive ...

Pancreatic cancer remains one of the most aggressive malignancies globally, with a historically poor prognosis and limited therapeutic options. Recent ...

Researchers have unveiled a groundbreaking marine-derived compound, known as Penicolinate H, that demonstrates remarkable potency against gastric cancer. This discovery ...

In a groundbreaking exploration that promises to reshape our understanding of cancer biology, researchers have delved into the multifaceted world ...

In a groundbreaking study published in BMC Cancer, researchers have unveiled the crucial role of TMEM88 in regulating the proliferation ...

A recent study investigating the role of ACSS2 in ovarian cancer cells has revealed startling insights into the mechanisms underpinning ...

Recent advancements in cancer treatment continue to evolve, with researchers exploring the intricate mechanisms that drive tumorigenesis. A pivotal study ...

In the relentless quest to unravel lung cancer’s molecular intricacies, emerging research spotlights an extraordinary phenomenon with transformative potential: biomolecular ...

Emerging insights into the biology of glioma stem cells (GSCs) reveal a complex interplay of phenotypic variations that significantly influence ...

Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...